Among these, TLR8-AS1 expression was associated with a favourable prognosis in up to seven malignancies, including LAML (HR = 3.86, p < .05), GBM (HR = 7.07, p < .001), KIRC (HR = 1094.82, p < .05), ACC (HR = 3928.22, p < .01), THCA (HR = 996958.39, p < .01), LGG (HR = 27894655.28, p < .01), and KICH (HR = 92551036.36, p < .05). The gene discussed is TLR8; the disease is glioblastoma.